Genome & Company (KOSDAQ:314130)
South Korea flag South Korea · Delayed Price · Currency is KRW
4,015.00
-205.00 (-4.86%)
At close: Oct 22, 2026

Genome & Company Financials Overview

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
24,46124,58727,74514,29614,085451.25
Revenue Growth
1.84%-11.38%94.07%1.50%3021.27%199.67%
Gross Profit
13,33113,40615,6704,0645,598374.24
Operating Income
-29,189-29,234-24,199-55,092-57,512-36,087
Net Income
-41,361-6,428-20,112-47,466-51,838-34,117
Earnings Per Share
-1180.23-205.30-660.20-1680.81-1841.50-1269.10
EPS Growth
------

Revenue by Geography

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
South Korea
13,71613,3696,3012,38614,085451.25
Asia
7,2135,9514,4287,188--
Europe
401.62785.017,372269.13--
South America
47.0831.1329.4615.04--
North America
3,0734,4379,6044,386--
Oceania
9.4213.7110.9752.16--
Total
24,46124,58727,74514,29614,085451.25

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
64,30136,83080,93086,272106,69977,164
Total Debt
24,81118,96732,02426,4536,2916,826
Net Cash (Debt)
39,49017,86248,90659,819100,40870,338
Net Cash Growth
23.96%-63.48%-18.24%-40.42%42.75%-34.77%
Net Cash Per Share
1126.83570.491605.362118.263566.882616.46

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-17,550-18,387-16,331-32,224-43,550-26,159
Capital Expenditures
-540.08-284.66-3,970-18,853-6,849-2,875
Free Cash Flow
-18,090-18,671-20,301-51,077-50,399-29,034
Free Cash Flow Growth
------

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
54.50%54.53%56.48%28.43%39.74%82.94%
Operating Margin
-119.33%-118.90%-87.22%-385.37%-408.34%-7997.20%
Pretax Margin
-182.27%-35.25%-101.69%-362.72%-412.03%-7978.71%
Profit Margin
-169.09%-26.14%-72.49%-332.02%-368.05%-7560.62%
FCF Margin
-73.95%-75.94%-73.17%-357.28%-357.83%-6434.20%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
8.589.703.0712.3317.461038.96